bioRxivMicrobiology
Bovine Lactoferrin Activity Against Chikungunya and Zika Viruses
Carlos A. M. Carvalho, Samir M. M. Casseb, Rafael B. Gonçalves, Eliana V. P. Silva, Andre M. O. Gomes, Pedro F. C. Vasconcelos
Abstract
Chikungunya (CHIKV) and Zika (ZIKV) viruses are two arboviruses which have recently broken their sylvatic isolation and gone into a rampant spreading among humans in some urban areas of the world, specially in Latin America. Given the huge burden that Chikungunya and Zika fevers impose to public health in the affected countries and the lack of effective interventions against them, the aim of this work was to evaluate the antiviral potential of bovine lactoferrin (bLf) - an iron-binding glycoprotein with broad-spectrum antimicrobial properties - in both CHIKV and ZIKV infections. The general antiviral activity of bLf was assessed by plaque assays, and the inhibitory effects of the protein on specific stages of virus infecion was evaluated by immunofluorescence and nucleic acid quantification assays. Our data show that bLf exerts a dose-dependent strong inhibitory effect on the infection of Vero cells by the aforementioned arboviruses, reducing their infection efficiency in up to nearly 80%, with no significant cytotoxicity, and such antiviral activity occurs at the levels of binding and replication of the virus particles. Taken together, these findings reveal that bLf antimicrobial properties are extendable to CHIKV and ZIKV, underlining a generic inhibition mechanism that can be explored to develop a potential strategy against their infections.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Beyond members of the Flaviviridae family, sofosbuvir also inhibits chikungunya virus replication
A. Ferreira, P. Reis, … T. Souza·bioRxiv·Jul 2, 2018
- Perturbation of alphavirus and flavivirus infectivity by components of the bacterial cell wall
L. Langendries, S. Jacobs, … L. Delang·bioRxiv·May 7, 2021
- A broad-spectrum, biocompatible, virucidal polymer reduces chikungunya virus in murine models
Shannan-Leigh Macleod, Anna X. Y. Loo, … Samuel T. Jones·bioRxiv·Oct 27, 2025
- The clinically approved antiviral drug sofosbuvir impairs Brazilian zika virus replication
Caroline Q. Sacramento, Gabrielle R. de Melo, … Thiago Souza·bioRxiv·Jul 6, 2016
- Chikungunya virus susceptibility increases in the absence of mk2b and mk3 genes in zebrafish model
Supriya Suman Keshry, Usharani Nayak, … Soma Chattopadhyay·bioRxiv·Mar 24, 2025
- Circulating apoB-containing lipoproteins constituted blood-borne innate immune barrier limits ZIKV dissemination and congenital infection risk
Juncheng Chen, Dawei Lv, … Gang Long·bioRxiv·Sep 16, 2026